WHO Functional Class IV Portopulmonary Hypertension When Triple Therapy Did Not Achieve Hemodynamic Targets
This protocol addresses the next step for patients with WHO functional class IV portopulmonary hypertension — or pulmonary hypertension not meeting low-risk criteria — after triple combination therapy has failed to achieve the required hemodynamic response on follow-up evaluation.
Clinical Scenario
Prostacyclin agonists are reserved for patients with WHO functional class IV or for any patient with pulmonary hypertension not meeting low-risk criteria. This high-severity subpopulation requires close hemodynamic monitoring and structured protocol-driven escalation when initial targets are not met.
Previous Treatment — Targets Not Achieved
The prior line consisted of triple therapy: a prostacyclin agonist combined with an endothelin receptor antagonist and a phosphodiesterase 5 inhibitor.
Mean pulmonary arterial pressure below 35 mm Hg and pulmonary vascular resistance below 3 WU — required on 3-month follow-up heart catheterization — were not achieved.
Next-Step Approach
For patients who have not met hemodynamic targets on triple therapy, guideline-recommended management considers orthotopic liver transplantation — with eligibility determined by specific hemodynamic criteria defined in the full protocol.
References
DOI: 10.1097/TXD.0000000000001517
- The prostacyclin agonists (prostanoids) are reserved for patients with a type IV functional class according to the World Health Organization or any patient with PH not meeting low-risk criteria.
- The AASLD guidelines suggest that OLT can be offered to patients with mild PoPH and those with an excellent response to medical treatment (MPAP after treatment <35 mm Hg and peripheral vascular resistance <3 WU).
- The guidelines of the International Society of Liver Transplantation, added to the recommendations of the AASLD, considers OLT for patients with MPAP that does not lower beneath <35 mm Hg with treatment, but there is, however, normalization of the peripheral vascular resistance (<3 WU).
View source ↗